Skip to content

C84.7B

Billable

Anaplastic large cell lymphoma, ALK-negative, in remission

HCC Category Mapping

V28HCC 19Lymphoma and Other Cancers
0.105
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

This is a type of aggressive blood cancer (lymphoma) that affects immune cells and does not have a specific genetic marker (ALK-negative), and the patient is currently in remission, meaning the cancer is not actively growing or detectable.

Coding Tips

  • Ensure documentation clearly states 'in remission' status, as this affects staging and prognosis coding; remission status must be explicitly documented by the physician
  • Verify the ALK-negative status is confirmed through pathology or molecular testing results, as this distinguishes it from ALK-positive anaplastic large cell lymphoma (C84.7A)

Clinical Significance

Anaplastic large cell lymphoma, ALK-negative, in remission indicates the patient has achieved disease control from this aggressive lymphoma. ALK-negative ALCL has lower remission rates than ALK-positive disease, making this a notable clinical milestone. Ongoing surveillance is essential due to the higher relapse risk associated with ALK-negative status.

Documentation Requirements

  • Original pathology confirming ALCL ALK-negative
  • Oncologist documentation explicitly stating remission status
  • Most recent imaging confirming no active disease
  • Surveillance plan documented
  • Treatment history including regimen received

Commonly Confused Codes

Code Hierarchy

Open C84.7B in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.